share_log

力生制药:监事会关于回购注销部分激励对象已获授但尚未解除限售的限制性股票的核查意见

Tianjin Lisheng Pharmaceutical: The opinion of the Supervisory Board regarding the verification of the repurchase and cancellation of restricted stocks that have been granted but have not yet been released from trading restrictions for the incentive targets.

SZSI ·  Aug 22
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more